Charles F. Wagner Jr., EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $454.79 ($3.0M) on 2024-05-28, disclosed to the SEC on 2024-05-30.
Scheduled sale ($3.0M) by EVP & Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $454.79 | 3,250 | $1.5M | 50.0% |
| 2 | $454.79 | 3,250 | $1.5M | 50.0% |
| Total | $454.79 avg | 6,500 | $3.0M | 100% |
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-11-13 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-06-05 | $1.5M | — | Filing → |